PB2696: QUALITATIVE INTERVIEWS TO DESCRIBE BURDEN IN PATIENTS (PT) WITH THIRD-LINE OR LATER CLL/SLL WITH PRIOR EXPOSURE TO BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYMPHOMA 2 INHIBITOR (BCL2I)

Detalles Bibliográficos
Autores principales: Priyadarshini, Masoom, Balantac, Zaneta, Tiwana, Simran K, Bapat, Shweta S, Garrison, Sean, Martin, Mona L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429382/
http://dx.doi.org/10.1097/01.HS9.0000977456.02322.4f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429382/
http://dx.doi.org/10.1097/01.HS9.0000977456.02322.4f

Ejemplares similares